News Duchenne drug available in England within weeks after NICE a... NHS England struck deal speeding access to drug.
News Scotland's Opdivo decision sparks funding row Patients in Scotland will receive lung cancer drug, those in England will not.
News Patients denied thyroid cancer drug in England Eisai considers legal action over funding "black hole".
News Pfizer leukaemia drug accepted by NICE Bosulif is first drug to be funded following reassessment.
R&D The long-delayed promise of the microbiome, with Sam Possemi... Sam Possemiers, CEO of MRM Health, believes that the microbiome space is finally coming into maturity.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
